Author
Ruben Cageling
0 works0 citations
Recent research
- Engineering & TechnologyOpen access
Bispecific antibody (BsAb) therapeutics have the ability to bind two targets simultaneously, which opens up new pathways for disease treatment. BsAbs consist of distinct heavy and light chains that need to be assembled correctly to form the appropriate heterodimer. However, durin...